Di Donato, Stefano
Alegre-Sancho, Juan José
Batalov, Anastas
Batalov, Zguro
Bellando-Randone, Silvia
Coccia, Carmela
De Pinto, Marco
Giuggioli, Dilia
Hughes, Michael https://orcid.org/0000-0003-3361-4909
Article History
Received: 19 January 2026
Revised: 5 May 2026
Accepted: 7 May 2026
First Online: 30 May 2026
Declarations
:
: Michael Hughes: reports Research Funding and Speaker Fees from Janssen; Conference Support from UCB; and Consultancy Fees from Boehringer Ingelheim and Novartis (none of which are relevant to this manuscript). Silvia Bellando Randone: Speaker fees and Consultancy fees from Boehringer Ingelheim. None of the other authors report any disclosures relevant to this manuscript.